Key facts
- This page summarizes Roman Trawicki's Form 4 filing for Zoetis Inc. (ZTS).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Mar 2022, 16:38.
Roman Trawicki - 16 Mar 2022 Form 4 Insider Report for Zoetis Inc. (ZTS)
- Reporting relationship
- Executive Vice President
- Issuer ticker
- ZTS
- Reported as of
- 16 Mar 2022
- Net transaction value
- -$603,840
- SEC form
- 4
- Accepted by SEC
- 18 Mar 2022, 16:38:00 UTC
- Prior SEC filing
- 15 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brenda Santuccio, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Roman Trawicki filed Form 4 for Zoetis Inc. (ZTS) on 18 Mar 2022.
Change
- Previous filing in this sequence was filed on 15 Feb 2022.
- Current net transaction value: -$603,840.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZTS
transaction
Common Stock
Options Exercise
- Transaction value
- $525,060
- Shares
- +6,000
- Change %
- +73%
- Price
- $87.51
- Shares after
- 14,218
- Date
- 16 Mar 2022
- Ownership
- Direct
ZTS
transaction
Common Stock
Sale
- Transaction value
- $1,128,900
- Shares
- -6,000
- Change %
- -42%
- Price
- $188.15
- Shares after
- 8,218
- Date
- 16 Mar 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZTS
transaction
Derivative
Stock Option
Options Exercise
- Transaction value
- $0
- Shares
- -6,000
- Change %
- -15%
- Price
- $0.000000
- Shares after
- 33,941
- Date
- 16 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,000
- Exercise price
- Footnotes
- F2, F3, F4, F5, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.10 to $188.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F2
Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
Footnote F3
6,000 options granted February 12, 2019 at an exercise price of $87.51 per option.
Footnote F4
Each option vests on the third anniversary of the date of grant.
Footnote F5
Each option expires on the tenth anniversary of the date of grant.
Footnote F6
7,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option; and 7,332 options granted February 8, 2022 at an exercise price of $201.30 per option.